Statistics for Eli Lilly & (id:8473 LLY)

Valuation metrics

Market cap

715.22B

Enterprise value

684.05B

Trailing P/E (ttm)

81.27

Forward P/E

33.25

PEG ratio

33.25

Price/Sales (ttm)

17.50

Price/Book (mrq)

47.61

Enterprise Value/Revenue

16.74

Enterprise Value/EBITDA

41.29

Overview

Shares outstanding

949.32M

Float

897.26M

Shares short

6.62M

% Held by insiders

0.00%

% Held by institutions

0.83%

Average volume (10 days)

5.23M

Average volume (90 days)

Price summary

52-Week low

561.65

52-Week high

972.53

52-Week change

20.22%

Beta

0.43

50-Day moving average

875.52

200-Day moving average

835.40

Dividends and splits

Forward annual dividend rate

5.20

Forward annual dividend yield

0.01

Trailing annual dividend rate

5.03%

Trailing annual dividend yield

0.01

5-Year annual dividend yield

1.26

Payout ratio

0.54

Dividend date

December 10th, 2024

Ex-dividend date

November 15th, 2024

Last split factor

2:1

Last split date

October 16th, 1997

Financials

Fiscal year

Fiscal year ends

December 31th, 2023

Most recent quarter (mrq)

September 30th, 2024

Profitability

Profit margin

20.48%

Operating margin

39.77%

Operational effectiveness

Return on assets

13.95%

Return on equity

65.32%

Income statement

Revenue (ttm)

45.37

Revenue per share (ttm)

45.37

Quarterly revenue growth (yoy)

Gross profit (ttm)

27.04B

EBITDA

16.72B

Net income to common (ttm)

8.37B

Diluted EPS (ttm)

9.27

Quarterly earnings growth (yoy)

Balance sheet

Total cash (mrq)

3.52B

Total cash per share (mrq)

3.91

Total debt (mrq)

31.23B

Total Debt/Equity (mrq)

218.08

Current ratio (mrq)

127.30%

Book value per share (mrq)

15.82

Cash flow

Cash flow statement

6.03B

Levered free cash flow (LFCF)

-1,306,887,552.00